Judge Construes Claims In Carbatrol Patent Fight

Law360, New York (March 28, 2008, 12:00 AM EDT) -- A federal judge delivered a mixed ruling in Shire Laboratories Inc.'s patent lawsuit against generics maker Corepharma LLC over Shire's anti-seizure drug Carbatrol, accepting Corepharma's proposed construction of one disputed term and rejecting its constructions of three others.

Judge Stanley Chesler handed down the ruling Wednesday in the U.S. District Court for the District of New Jersey.

Shire brought the suit in 2006 when Corepharma filed an abbreviated new drug application with the U.S. Food and Drug Administration to sell to manufacture generic versions of Shire's...
To view the full article, register now.